四电极脑深部电刺激治疗多灶性药物难治性癫痫:手术安全性及初步疗效
该研究回顾性分析了32例接受四电极脑深部电刺激(DBS)植入的多灶性药物难治性癫痫患者,随访至少6个月。结果显示手术安全,无感染或出血,多数患者获益,中位患者报告癫痫减少率为70%,应答率为72%。
要点
- 四电极DBS治疗多灶性药物难治性癫痫安全,无感染或出血并发症。
- 中位患者报告癫痫减少率为70%,应答率为72%。
- 22%患者达到Engel I级,22%为II级,28%为III级,28%为IV级。
核心结论
- 四电极DBS对于多灶性药物难治性癫痫是安全的,在具有挑战性的病例中可实现有意义的改善,且并发症率低。
研究设计与样本
- 回顾性连续病例系列,纳入32例接受四电极DBS植入且随访至少6个月的患者,提取人口学、结局和并发症数据。
主要发现
- 手术时中位年龄28.5岁,癫痫诊断中位年龄7.5岁,女性18例(56%),植入前中位癫痫病程21年。
- 最常见癫痫定位为额颞叶(53%),其次为全面性(28%)和顶枕叶(13%)。
- 20例(63%)曾尝试迷走神经刺激,17例(59%)进行过侵入性立体脑电图记录,8例(25%)有既往癫痫手术史。
- DBS靶点包括前丘脑核联合中央中丘脑核、海马、枕核、扣带回、岛叶和苍白球。
- 中位手术时长5小时22分钟,中位手术室时间8小时21分钟,中位术后随访27个月(四分位距17-41)。
关键数值与推荐
- Engel分级:I级22%,II级22%,III级28%,IV级28%。
- 中位患者报告癫痫减少率70%,应答率72%。
临床怎么用
- 四电极DBS可作为多灶性药物难治性癫痫的一种安全治疗选择,需注意短暂神经功能缺损和电极调整可能。
局限性
- 回顾性设计,样本量较小(32例),随访时间有限,缺乏对照組。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Deep brain stimulation (DBS) is emerging as an additional surgical option for refractory, multifocal epilepsy. Four-lead DBS systems can be used when seizure onset is poorly localized, generalized, or involves multiple targetable circuits. The goal of this study was to assess preliminary outcomes and complication rates in 4-lead DBS systems for treating epilepsy. METHODS: A consecutive series of 32 patients with 4-lead DBS implants who had at least 6 months of follow-up was reviewed, and demographics, outcomes, and complications were abstracted. RESULTS: Thirty-two patients implanted with 4 DBS leads (including off-label use) were included. The median age at surgery was 28.5 years, the median age at epilepsy diagnosis was 7.5 years, and 18 patients (56%) were women. The median epilepsy duration prior to implantation was 21 years. The most common seizure localization was frontotemporal (53%), followed by generalized (28%) and parietoccipital (13%). Prior vagus nerve stimulation had been trialed in 20 patients (63%), and an invasive stereotactic EEG recording was performed in 17 patients (59%). Eight patients had prior epilepsy surgery (25%). DBS targets included the anterior thalamic nucleus in combination with the centromedian thalamic nucleus, hippocampus, pulvinar nucleus, cingulate, insula, and globus pallidus. The median surgical duration was 5 hours 22 minutes, with a median operating room time of 8 hours 21 minutes. The median postoperative follow-up was 27 (interquartile range 17-41) months. Three patients experienced transient neurological deficits and 2 patients required intraoperative lead repositioning. There were no infections or hemorrhages. Most patients benefited from stimulation (22% Engel class I, 22% class II, 28% class III, and 28% class IV). The median patient-reported seizure reduction rate was 70%, with a responder rate of 72%. One patient elected to have the system explanted. CONCLUSIONS: Four-lead DBS is safe and can achieve meaningful improvement in challenging cases of multifocal epilepsy with a low complication rate.
引用
- Peters PA, Zhou R, Singh R, et al. Four-lead deep brain stimulation for multifocal drug-resistant epilepsy: surgical safety profile and preliminary effectiveness. J Neurosurg. 2026. PMID: 41569668. doi:10.3171/2025.8.JNS251288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。